232 related articles for article (PubMed ID: 20463906)
1. Toxicology and drug delivery by cucurbit[n]uril type molecular containers.
Hettiarachchi G; Nguyen D; Wu J; Lucas D; Ma D; Isaacs L; Briken V
PLoS One; 2010 May; 5(5):e10514. PubMed ID: 20463906
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel interaction with cucurbit [7]uril and acyclic Cucurbit[4]uril nanocontainers: A computational approach.
Ahmadian N; Amininasab M; Mehrnejad F
J Mol Graph Model; 2019 Jul; 90():210-218. PubMed ID: 31103913
[TBL] [Abstract][Full Text] [Related]
3. Toxicity of cucurbit[7]uril and cucurbit[8]uril: an exploratory in vitro and in vivo study.
Uzunova VD; Cullinane C; Brix K; Nau WM; Day AI
Org Biomol Chem; 2010 May; 8(9):2037-42. PubMed ID: 20401379
[TBL] [Abstract][Full Text] [Related]
4. Acyclic cucurbit[n]uril molecular containers enhance the solubility and bioactivity of poorly soluble pharmaceuticals.
Ma D; Hettiarachchi G; Nguyen D; Zhang B; Wittenberg JB; Zavalij PY; Briken V; Isaacs L
Nat Chem; 2012 Apr; 4(6):503-10. PubMed ID: 22614387
[TBL] [Abstract][Full Text] [Related]
5. Stimuli responsive systems constructed using cucurbit[n]uril-type molecular containers.
Isaacs L
Acc Chem Res; 2014 Jul; 47(7):2052-62. PubMed ID: 24785941
[TBL] [Abstract][Full Text] [Related]
6. Molecular Insight into the Interaction between Camptothecin and Acyclic Cucurbit[4]urils as Efficient Nanocontainers in Comparison with Cucurbit[7]uril: Molecular Docking and Molecular Dynamics Simulation.
Ahmadian N; Mehrnejad F; Amininasab M
J Chem Inf Model; 2020 Mar; 60(3):1791-1803. PubMed ID: 31944098
[TBL] [Abstract][Full Text] [Related]
7. Supramolecular Chemotherapy with Cucurbit[
Shukla S; Sagar B; Sood AK; Gaur A; Batra S; Gulati S
ACS Appl Bio Mater; 2023 Jun; 6(6):2089-2101. PubMed ID: 37224296
[TBL] [Abstract][Full Text] [Related]
8. Cucurbit[7]uril: an emerging candidate for pharmaceutical excipients.
Kuok KI; Li S; Wyman IW; Wang R
Ann N Y Acad Sci; 2017 Jun; 1398(1):108-119. PubMed ID: 28692768
[TBL] [Abstract][Full Text] [Related]
9. Toxicity of hemimethyl-substituted cucurbit[7]uril.
Yang X; Zhao W; Wang Z; Huang Y; Lee SMY; Tao Z; Wang R
Food Chem Toxicol; 2017 Oct; 108(Pt B):510-518. PubMed ID: 28082230
[TBL] [Abstract][Full Text] [Related]
10. Complexation of clofazimine by macrocyclic cucurbit[7]uril reduced its cardiotoxicity without affecting the antimycobacterial efficacy.
Li S; Chan JY; Li Y; Bardelang D; Zheng J; Yew WW; Chan DP; Lee SM; Wang R
Org Biomol Chem; 2016 Aug; 14(31):7563-9. PubMed ID: 27439674
[TBL] [Abstract][Full Text] [Related]
11. Acyclic Cucurbit[n]uril-Type Molecular Container Enables Systemic Delivery of Effective Doses of Albendazole for Treatment of SK-OV-3 Xenograft Tumors.
Hettiarachchi G; Samanta SK; Falcinelli S; Zhang B; Moncelet D; Isaacs L; Briken V
Mol Pharm; 2016 Mar; 13(3):809-18. PubMed ID: 26756920
[TBL] [Abstract][Full Text] [Related]
12. Topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril.
Seif M; Impelido ML; Apps MG; Wheate NJ
PLoS One; 2014; 9(1):e85361. PubMed ID: 24454850
[TBL] [Abstract][Full Text] [Related]
13. Acyclic Cucurbit[n]uril-Type Molecular Containers: Influence of Linker Length on Their Function as Solubilizing Agents.
Sigwalt D; Moncelet D; Falcinelli S; Mandadapu V; Zavalij PY; Day A; Briken V; Isaacs L
ChemMedChem; 2016 May; 11(9):980-9. PubMed ID: 26990780
[TBL] [Abstract][Full Text] [Related]
14. Acyclic cucurbit[n]uril-type molecular containers: influence of aromatic walls on their function as solubilizing excipients for insoluble drugs.
Zhang B; Isaacs L
J Med Chem; 2014 Nov; 57(22):9554-63. PubMed ID: 25369565
[TBL] [Abstract][Full Text] [Related]
15. The cucurbit[n]uril family.
Lagona J; Mukhopadhyay P; Chakrabarti S; Isaacs L
Angew Chem Int Ed Engl; 2005 Aug; 44(31):4844-70. PubMed ID: 16052668
[TBL] [Abstract][Full Text] [Related]
16. Improving platinum(II)-based anticancer drug delivery using cucurbit[n]urils.
Wheate NJ
J Inorg Biochem; 2008 Dec; 102(12):2060-6. PubMed ID: 18653238
[TBL] [Abstract][Full Text] [Related]
17. Cucurbit[7]uril encapsulated cisplatin overcomes cisplatin resistance via a pharmacokinetic effect.
Plumb JA; Venugopal B; Oun R; Gomez-Roman N; Kawazoe Y; Venkataramanan NS; Wheate NJ
Metallomics; 2012 Jun; 4(6):561-7. PubMed ID: 22610518
[TBL] [Abstract][Full Text] [Related]
18. Templated synthesis of glycoluril hexamer and monofunctionalized cucurbit[6]uril derivatives.
Lucas D; Minami T; Iannuzzi G; Cao L; Wittenberg JB; Anzenbacher P; Isaacs L
J Am Chem Soc; 2011 Nov; 133(44):17966-76. PubMed ID: 21970313
[TBL] [Abstract][Full Text] [Related]
19. Uptake of Hydrocarbons in Aqueous Solution by Encapsulation in Acyclic Cucurbit[n]uril-Type Molecular Containers.
Lu X; Isaacs L
Angew Chem Int Ed Engl; 2016 Jul; 55(28):8076-80. PubMed ID: 27169688
[TBL] [Abstract][Full Text] [Related]
20. Acyclic Cucurbit[n]uril-type Receptors: Preparation, Molecular Recognition Properties and Biological Applications.
Ganapati S; Isaacs L
Isr J Chem; 2018 Apr; 58(3-4):250-263. PubMed ID: 29805180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
